Search Results

There are 2317 results for: content related to: Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

  1. You have full text access to this OnlineOpen article
    Abstracts

    Research and Practice in Thrombosis and Haemostasis

    Volume 1, Issue S1, July 2017, Pages: 1–1451,

    Version of Record online : 23 JUN 2017, DOI: 10.1002/rth2.12012

  2. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  3. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Version of Record online : 19 NOV 2013, DOI: 10.1002/clc.22204

  4. Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban

    The Journal of Clinical Pharmacology

    Volume 50, Issue 9, September 2010, Pages: 986–1000, Jason Morell, Bridgette Sullivan, Marina Khalabuda and Brian F. McBride

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009355814

  5. You have free access to this content
    Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives

    European Journal of Haematology

    Volume 95, Issue 5, November 2015, Pages: 389–404, Antonio Gómez-Outes, Mª Luisa Suárez-Gea, Ramón Lecumberri, Ana Isabel Terleira-Fernández and Emilio Vargas-Castrillón

    Version of Record online : 16 JUL 2015, DOI: 10.1111/ejh.12610

  6. You have full text access to this OnlineOpen article
    Stroke prevention with rivaroxaban in higher-risk populations with atrial fibrillation

    International Journal of Clinical Practice

    Volume 69, Issue 7, July 2015, Pages: 743–756, H.-C. Diener, J. L. Halperin, K. Fox and G. J. Hankey

    Version of Record online : 9 APR 2015, DOI: 10.1111/ijcp.12631

  7. You have free access to this content
    Rivaroxaban for the treatment and prevention of thromboembolic disease

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 8, August 2015, Pages: 1119–1132, Sotiris Antoniou

    Version of Record online : 9 JUN 2015, DOI: 10.1111/jphp.12387

  8. You have free access to this content
    New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation

    Journal of Internal Medicine

    Volume 271, Issue 6, June 2012, Pages: 554–565, A. Tripodi and G. Palareti

    Version of Record online : 19 APR 2012, DOI: 10.1111/j.1365-2796.2012.02541.x

  9. New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 975–1016, Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich and Jennifer A. Campbell

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.975

  10. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue S1, May 2016, Pages: 1–168,

    Version of Record online : 13 MAY 2016, DOI: 10.1111/jth.13325

  11. Preliminary report: Measurement of apixaban and rivaroxaban in plasma from bleeding patients

    European Journal of Haematology

    Accepted manuscript online: 21 AUG 2017, Kathrine O.F. Jensen, Svend H. Hansen, Jens P. Goetze, Amalie Jesting, Jakob Stensballe and Henrik Hansen

    DOI: 10.1111/ejh.12942

  12. New Avenues for Anticoagulation in Atrial Fibrillation

    Clinical Pharmacology & Therapeutics

    Volume 93, Issue 1, January 2013, Pages: 68–77, S Mantha, K Cabral and J Ansell

    Version of Record online : 5 DEC 2012, DOI: 10.1038/clpt.2012.197

  13. You have free access to this content
    Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 628–636, Y. Lu, R. Branstad, R. M. Karim and R. W. Asinger

    Version of Record online : 24 SEP 2014, DOI: 10.1111/jcpt.12207

  14. You have free access to this content
    Drug and dietary interactions of the new and emerging oral anticoagulants

    International Journal of Clinical Practice

    Volume 64, Issue 7, June 2010, Pages: 956–967, J. M. Walenga and C. Adiguzel

    Version of Record online : 17 MAY 2010, DOI: 10.1111/j.1742-1241.2009.02286.x

  15. You have free access to this content
    Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

    Journal of Internal Medicine

    Volume 278, Issue 1, July 2015, Pages: 1–18, A. M. Shields and G. Y. H. Lip

    Version of Record online : 15 APR 2015, DOI: 10.1111/joim.12360

  16. You have free access to this content
    Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 707–717, Yoon K. Loke, Shiva Pradhan, Jessica Ka-yan Yeong and Chun Shing Kwok

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12376

  17. Pharmacology and mechanisms of action of new oral anticoagulants

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 1, February 2015, Pages: 10–20, Joe-Elie Salem, Pierre Sabouret, Christian Funck-Brentano and Jean-Sebastien Hulot

    Version of Record online : 25 SEP 2014, DOI: 10.1111/fcp.12091

  18. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  19. You have free access to this content
    Alternatives to Warfarin—The Next Generation of Anticoagulants

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: e80–e88, Pamala Kanagasabapathy, Pratima Chowdary and Alex Gatt

    Version of Record online : 9 JUL 2010, DOI: 10.1111/j.1755-5922.2010.00197.x

  20. You have free access to this content
    Multimodal assessment of non-specific hemostatic agents for apixaban reversal

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 3, March 2015, Pages: 426–436, A.-C. Martin, I. Gouin-Thibault, V. Siguret, A. Mordohay, C.-M. Samama, P. Gaussem, B. Le Bonniec and A. Godier

    Version of Record online : 5 FEB 2015, DOI: 10.1111/jth.12830